Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
59 studies found for:    Cholecystokinin
Show Display Options
Rank Status Study
1 Terminated Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa
Conditions: Bulimia Nervosa;   Eating Disorders
Interventions: Procedure: Cholecystokinin (CCK) infusion;   Procedure: Saline infusion
2 Recruiting Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Isotonic saline;   Drug: Metformin placebo;   Drug: Cholecystokinin;   Drug: Metformin
3 Completed
Has Results
A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Albiglutide 50 mg;   Drug: Placebo;   Drug: CCK (Kinevac)
4 Recruiting Effect of Bile Acid Secretion and Sequestration on GLP-1 Secretion
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Sevelamer;   Drug: Cholecystokinin;   Drug: Sevelamer placebo;   Drug: Isotonic saline
5 Not yet recruiting Fatty Acids in Airway Smooth Muscle of Asthmatics
Condition: Asthma
Intervention: Dietary Supplement: coconut oil
6 Recruiting 177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.
Condition: Thyroid Cancer, Medullary
Intervention: Drug: 177Lu-PP-F11N
7 Completed Mechanism of Action of Vichy Catalan Water
Condition: Cardiovascular Diseases
Interventions: Dietary Supplement: Bicarbonated mineral water;   Dietary Supplement: Mineral water low in mineral content (control)
8 Completed The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion
Condition: To Assess the Impact of Bile Acids on Human Glukagon-like-peptide-1 Secretion
Interventions: Drug: Acetaminophen;   Drug: Metformin;   Drug: Colesevelam;   Other: Cholecystokinin-8;   Other: Saline
9 Completed Hormone Release and Stomach Disturbances in People With Binge Eating Disorder
Conditions: Binge Eating Disorder;   Obesity;   Eating Disorders
Intervention:
10 Completed Endoscopic Ultrasound Compared With Pancreatic Function Testing for Diagnosis of Chronic Pancreatitis
Condition: Chronic Pancreatitis
Intervention: Device: EUS
11 Withdrawn Investigation of Neuro-hormonal Mechanisms of Hunger, Fullness and Obesity.
Conditions: Obesity;   Gastric Emptying;   Anxiety;   Depression;   Panic Disorder
Intervention:
12 Completed Peanuts Second Meal Glycemic Response
Condition: Type 2 Diabetes Mellitus
Intervention: Dietary Supplement: Whole peanuts without skins, Peanut butter, or no peanuts (control)
13 Recruiting Evaluation of Gallbladder Contractility Using Both CCK and Milk Consecutively
Condition: Abdominal Pain
Interventions: Other: Milk;   Biological: CCK
14 Completed DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS)
Condition: Irritable Bowel Syndrome
Intervention: Drug: dexloxiglumide
15 Completed Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)
Condition: Healthy Volunteers
Interventions: Drug: Sincalide;   Drug: Ursodiol Acid;   Procedure: High Fat/Low Fat Diet
16 Unknown  Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease in Diabetic Patients
Conditions: Nonalcoholic Fatty Liver Disease (NAFLD).;   Nonalcoholic Steatohepatitis.;   Diabetes.
Interventions: Procedure: Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG).;   Other: Low carbohydrate diet
17 Completed Effects of Roux-en-Y Gastric Bypass on Gastro-intestinal Hormone Secretion and Brain Responses Food Pictures
Condition: Obesity
Intervention: Other: standard test meal
18 Completed Sincalide (Cholecystokinin Octapeptide) Versus Placebo in Neonates at High Risk for Developing Parenteral Nutrition Associated Cholestasis
Condition: Cholestasis
Intervention: Drug: sincalide
19 Unknown  Three New Methods for Diagnosing Pancreas Cancer
Condition: Pancreas Cancer
Intervention: Procedure: Ultrasound and contrast agent
20 Completed Safety, Tolerability and Pharmacokinetics of Single Rising Doses of YF476, a Gastrin Antagonist, in Healthy Men
Condition: Reflux Oesophagitis
Intervention: Drug: YF476

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years